Target Name: SGCG
NCBI ID: G6445
Review Report on SGCG Target / Biomarker Content of Review Report on SGCG Target / Biomarker
SGCG
Other Name(s): 35kD dystrophin-associated glycoprotein | Sarcoglycan gamma, transcript variant 1 | DAGA4 | A4 | DMDA | SCARMD2 | sarcoglycan, gamma (35kDa dystrophin-associated glycoprotein) | Gamma-sarcoglycan | Gamma-sarcoglycan isoform 1 | gamma-SG | DMDA1 | LGMD2C | LGMDR5 | SGCG variant 1 | Gamma-SG | 35DAG | 35 kDa dystrophin-associated glycoprotein | SGCG_HUMAN | MAM | SCG3 | sarcoglycan gamma

SGCG: A Protein Linked To Dystrophin and Many Other Importance Processes

SGCG, also known as dystrophin-associated glycoprotein (DAG), is a protein that is expressed in the body to help maintain the health and structure of the bones and joints. It is a member of the glycoprotein family, which is a type of protein that consists of a glycan molecule and a protein tail. SGCG is unique because it is associated with dystrophin, a protein that helps keep bones and joints strong and healthy.

Dystrophin is a protein that is found in almost all cells in the body. It is made up of four chains of amino acids and has a cytoplasmic tail that is responsible for giving it its name. Dystrophin is important for maintaining the health and structure of the bones and joints because it helps keep them strong and healthy. It is also involved in many other processes in the body, including the regulation of inflammation and the transport of oxygen and nutrients to cells throughout the body.

SGCG is a protein that is made up of a glycan molecule and a protein tail. The glycan molecule is a type of sugar that is attached to the protein. The protein tail is the long, flexible tail that is attached to the end of the protein. SGCG is often used as a drug target or biomarker because of its unique structure and the fact that it is associated with dystrophin.

One of the reasons why SGCG is an attractive drug target is because it is involved in many important processes in the body. For example, SGCG is involved in the regulation of inflammation, which is important for maintaining the health and structure of the bones and joints. It is also involved in the transport of oxygen and nutrients to cells throughout the body, which is important for maintaining the health and function of all of the cells in the body.

In addition to its role in maintaining the health and structure of the bones and joints, SGCG is also involved in many other important processes in the body. For example, it is involved in the regulation of cell growth and differentiation, which is important for the development and maintenance of all of the cells in the body. It is also involved in the regulation of protein synthesis, which is important for the production and repair of proteins.

SGCG is also unique because of its association with dystrophin. Dystrophin is a protein that is found in almost all cells in the body and is responsible for helping keep bones and joints strong and healthy. By being associated with dystrophin, SGCG is able to interact with the protein and potentially influence its function. This makes SGCG an attractive drug target because it has the potential to treat a wide range of diseases and conditions that are associated with dystrophin dysfunction.

In conclusion, SGCG is a protein that is associated with dystrophin and is made up of a glycan molecule and a protein tail. It is unique because of its structure and the fact that it is involved in many important processes in the body. As a result, SGCG is an attractive drug target and has the potential to treat a wide range of diseases and conditions that are associated with dystrophin dysfunction.

Protein Name: Sarcoglycan Gamma

Functions: Component of the sarcoglycan complex, a subcomplex of the dystrophin-glycoprotein complex which forms a link between the F-actin cytoskeleton and the extracellular matrix

The "SGCG Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SGCG comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

SGCZ | SGF29 | SGIP1 | SGK1 | SGK2 | SGK3 | SGMS1 | SGMS1-AS1 | SGMS2 | SGO1 | SGO1-AS1 | SGO2 | SGPL1 | SGPP1 | SGPP2 | SGSH | SGSM1 | SGSM2 | SGSM3 | SGTA | SGTB | SH2B1 | SH2B2 | SH2B3 | SH2D1A | SH2D1B | SH2D2A | SH2D3A | SH2D3C | SH2D4A | SH2D4B | SH2D5 | SH2D6 | SH2D7 | SH3 domain-binding protein 1 | SH3BGR | SH3BGRL | SH3BGRL2 | SH3BGRL3 | SH3BP1 | SH3BP2 | SH3BP4 | SH3BP5 | SH3BP5-AS1 | SH3BP5L | SH3D19 | SH3D21 | SH3GL1 | SH3GL1P1 | SH3GL1P2 | SH3GL1P3 | SH3GL2 | SH3GL3 | SH3GLB1 | SH3GLB2 | SH3KBP1 | SH3PXD2A | SH3PXD2A-AS1 | SH3PXD2B | SH3RF1 | SH3RF2 | SH3RF3 | SH3RF3-AS1 | SH3TC1 | SH3TC2 | SH3TC2-DT | SH3YL1 | SHANK1 | SHANK2 | SHANK2-AS1 | SHANK2-AS3 | SHANK3 | SHARPIN | SHB | SHBG | SHC1 | SHC2 | SHC3 | SHC4 | SHCBP1 | SHCBP1L | SHD | SHE | SHF | SHFL | SHH | SHISA2 | SHISA3 | SHISA4 | SHISA5 | SHISA6 | SHISA7 | SHISA8 | SHISA9 | SHISAL1 | SHISAL2A | SHISAL2B | SHKBP1 | SHLD1 | SHLD2